Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (171-180 of 270) with videos related to

Pageof 27
Sort By:
Cellular & Molecular Immunology|May 17, 2016
BCR-ABL-specific CD4<sup>+</sup> T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cellsNorihiro Ueda, Rong Zhang, Minako Tatsumi, et al.
Nature Communications|March 26, 2022
Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cellsNaomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim, et al.
International Journal of Hematology|January 17, 2025
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significanceSatoshi Nishiwaki, Seitaro Terakura, Takanobu Morishita, et al.
Stem Cells Translational Medicine|December 14, 2020
Phase I clinical trial of intra-bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantationTatsunori Goto, Makoto Murata, Tetsuya Nishida, et al.
International Journal of Hematology|August 10, 2023
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterpartsErina Takagi, Seitaro Terakura, Hidetsugu Fujigaki, et al.
Leukemia Research|September 29, 2006
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival ratesMasamitsu Yanada, Itsuro Jinnai, Jin Takeuchi, et al.
Cancer Science|February 28, 2012
Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 studyKazunori Ohnishi, Chiaki Nakaseko, Jin Takeuchi, et al.
Blood|June 23, 2009
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocationYukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2014
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cellsKeisuke Watanabe, Seitaro Terakura, Anton C Martens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2021
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survivalJakrawadee Julamanee, Seitaro Terakura, Koji Umemura, et al.
Pageof 27

Showing results (171-180 of 270) with videos related to

Sort By:
Pageof 27
Cellular & Molecular Immunology|May 17, 2016
BCR-ABL-specific CD4<sup>+</sup> T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cellsNorihiro Ueda, Rong Zhang, Minako Tatsumi, et al.
Nature Communications|March 26, 2022
Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cellsNaomi Kawashima, Yuichi Ishikawa, Jeong Hui Kim, et al.
International Journal of Hematology|January 17, 2025
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significanceSatoshi Nishiwaki, Seitaro Terakura, Takanobu Morishita, et al.
Stem Cells Translational Medicine|December 14, 2020
Phase I clinical trial of intra-bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantationTatsunori Goto, Makoto Murata, Tetsuya Nishida, et al.
International Journal of Hematology|August 10, 2023
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterpartsErina Takagi, Seitaro Terakura, Hidetsugu Fujigaki, et al.
Leukemia Research|September 29, 2006
Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults: a low initial white blood cell count, as well as a high count predict decreased survival ratesMasamitsu Yanada, Itsuro Jinnai, Jin Takeuchi, et al.
Cancer Science|February 28, 2012
Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 studyKazunori Ohnishi, Chiaki Nakaseko, Jin Takeuchi, et al.
Blood|June 23, 2009
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocationYukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2014
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cellsKeisuke Watanabe, Seitaro Terakura, Anton C Martens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2021
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survivalJakrawadee Julamanee, Seitaro Terakura, Koji Umemura, et al.
Pageof 27